HEARING - U.S. Senate Special Committee on Aging
HEARING - U.S. Senate Special Committee on Aging
HEARING - U.S. Senate Special Committee on Aging
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
117<br />
-2-<br />
3. Deceptive marketinq practices. Throughout California<br />
(and probably in other states as well), senior<br />
citizens have been sent mailings that appear to be<br />
official government notices of cuts in Medicare<br />
benefits and the need to buy medigap insurance. In<br />
fact, the mailings are from an insurance company and<br />
firms which develop and sell sales leads to insurance<br />
agents.<br />
4. Hihco low value. Finally, Medicare supplement<br />
insurance polices tend to be relatively high-cost,<br />
low-value policies. Premiums range from $150 to<br />
$1,500 per year. Loss ratios, the percentage of<br />
premiums collected that are paid in benefits, average<br />
60% for commercial medicare supplement policies,<br />
according to a recent GAO report. This means that <strong>on</strong><br />
average the costs of marketing, administrati<strong>on</strong>, and<br />
profits c<strong>on</strong>sume 40% of premiuma collected from<br />
c<strong>on</strong>sumers. Mutual of Omaha, the company that Mr.<br />
Shapland represents, had a loss ratio of 51.0%. This<br />
is not a record to be particularly proud of,<br />
especially in light of the target minimum loss ratio<br />
of 60% that Mr. Shapland menti<strong>on</strong>s. By way of<br />
comparis<strong>on</strong>, Medicare's administrative costs are 3% of<br />
revenues. Displacing all or part of the private<br />
market by an expanded Medicare promises to increase<br />
c<strong>on</strong>sumers' value-for-m<strong>on</strong>ey.<br />
C<strong>on</strong>sumers Uni<strong>on</strong> str<strong>on</strong>gly endorses expanding Medicare to<br />
cover the costs of catastrophic illness, and believes that<br />
sp<strong>on</strong>sorship by the federal government is warranted. We urge you<br />
to remember the poor performance of the medigap market in<br />
c<strong>on</strong>sidering opti<strong>on</strong>s for l<strong>on</strong>g-term care.<br />
Thank you for the opportunity to present these additi<strong>on</strong>al<br />
views.<br />
Sincerely,<br />
Gail Shearer<br />
Manager, Policy Analysis